Compare DIT & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIT | MBOT |
|---|---|---|
| Founded | 1981 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.4M | 73.2M |
| IPO Year | 1996 | 2000 |
| Metric | DIT | MBOT |
|---|---|---|
| Price | $62.24 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 980.0 | ★ 841.0K |
| Earning Date | 11-09-2026 | 11-24-2026 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | ★ 173.91 | 60.27 |
| EPS | ★ 2.52 | N/A |
| Revenue | ★ $1,392,388,157.00 | $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $377.83 |
| P/E Ratio | $24.70 | ★ N/A |
| Revenue Growth | ★ 5.30 | N/A |
| 52 Week Low | $59.15 | $0.93 |
| 52 Week High | $118.50 | $2.86 |
| Indicator | DIT | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 46.63 |
| Support Level | $59.58 | N/A |
| Resistance Level | $65.04 | $1.18 |
| Average True Range (ATR) | 1.97 | 0.08 |
| MACD | 0.20 | 0.02 |
| Stochastic Oscillator | 20.60 | 49.79 |
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.